Transcriptional Program of Mouse Osteoclast Differentiation Governed by the Macrophage Colony-stimulating Factor and the Ligand for the Receptor Activator of NFκB

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439 · see citing works

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224 · see citing works

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.

Hsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636 · see citing works

Minireview: The OPG/RANKL/RANK System

Khosla, S. (2001) · Endocrinology · doi:10.1210/endo.142.12.8536 · Cited by 1,515 · see citing works

RANK is essential for osteoclast and lymph node development.

Dougall, W. C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M. E., Maliszewski, C. R., et al. (1999) · Genes & Development · doi:10.1101/gad.13.18.2412 · Cited by 1,478 · see citing works

T-Cell mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ.

Takayanagi, H., Ogasawara, K., Hida, S., Chiba, T., Murata, S., Sato, K., Takaoka, A., Yokochi, T., Oda, H., Tanaka, K., et al. (2000) · Nature · doi:10.1038/35046102 · Cited by 1,358 · see citing works

The Roles of Osteoprotegerin and Osteoprotegerin Ligand in the Paracrine Regulation of Bone Resorption

Hofbauer, L. C., Khosla, S., Dunstan, C. R., Lacey, D. L., Boyle, W. J., & Riggs, B. L. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.1.2 · Cited by 1,167 · see citing works

RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis, and regulation of bone mass and calcium metabolism.

Li, J., Sarosi, I., Yan, X.-Q., Morony, S., Capparelli, C., Tan, H.-L., McCabe, S., Elliott, R., Scully, S., Van, G., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1566 · Cited by 1,119 · see citing works

Requirement for NF-κB in osteoclast and B-cell development

Franzoso, G., Carlson, L., Xing, L., Poljak, L., Shores, E. W., Brown, K. D., Leonardi, A., Tran, T., Boyce, B. F., & Siebenlist, U. (1997) · Genes & Development · doi:10.1101/gad.11.24.3482 · Cited by 996 · see citing works

Osteopetrosis in mice lacking NF-κB1 and NF-κB2

Iotsova, V., Caamaño, J., Loy, J. K., Yang, Y., Lewin, A. C., & Bravo, R. (1997) · Nature Medicine · doi:10.1038/nm1197-1285 · Cited by 990 · see citing works

Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors.

Arai, F., Miyamoto, T., Ohneda, O., Inada, T., Sudo, T., Brasel, K., Miyata, T., Anderson, D. M., & Suda, T. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.12.1741 · Cited by 693 · see citing works

Primer on the metabolic bone diseases and disorders of mineral metabolism.

Laurence, M. (2000) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.82b7.0821087b · Cited by 684 · see citing works

Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene

Tassabehji, M., Newton, V. E., & Read, A. (1994) · Nature Genetics · doi:10.1038/ng1194-251 · Cited by 670 · see citing works

Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis

Frattini, A., Orchard, P. J., Sobacchi, C., Giliani, S. C., Abinun, M., Mattsson, J. P., Keeling, D. J., Andersson, A., Wallbrandt, P., Zecca, L., et al. (2000) · Nature Genetics · doi:10.1038/77131 · Cited by 669 · see citing works

Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors.

Tanaka, S., Takahashi, N., Udagawa, N., Tamura, T., Akatsu, T., Stanley, E. R., Kurokawa, T., & Suda, T. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116179 · Cited by 573 · see citing works

Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-jun repression.

Shevde, N. K., Bendixen, A. C., Dienger, K. M., & Pike, J. W. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.130200197 · Cited by 502 · see citing works

Tumor Necrosis Factor-α (TNF) Stimulates RANKL-induced Osteoclastogenesis via Coupling of TNF Type 1 Receptor and RANK Signaling Pathways

Zhang, Y.-H., Heulsmann, A., Tondravi, M. M., Mukherjee, A., & Abu‐Amer, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008198200 · Cited by 496 · see citing works

Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis

Hughes, A. E., Ralston, S. H., Marken, J., Bell, C., Macpherson, H. K., Wallace, R. G. H., Hul, W. V., Whyte, M. P., Nakatsuka, K., Hovy, L., et al. (2000) · Nature Genetics · doi:10.1038/71667 · Cited by 481 · see citing works

Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification

Li, Y., Chen, W., Liang, Y., Li, E., & Stashenko, P. (1999) · Nature Genetics · doi:10.1038/70563 · Cited by 467 · see citing works

A New Member of Tumor Necrosis Factor Ligand Family, ODF/OPGL/TRANCE/RANKL, Regulates Osteoclast Differentiation and Function

Takahashi, N., Udagawa, N., & Suda, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0252 · Cited by 461 · see citing works

The TRAF Family of Signal Transducers Mediates NF-κB Activation by the TRANCE Receptor

Wong, B. R., Josien, R., Lee, S. Y., Vologodskaia, M., Steinman, R. M., & Choi, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.28355 · Cited by 458 · see citing works

Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation

Arber, S. (1994) · Cell · doi:10.1016/0092-8674(94)90192-9 · Cited by 441 · see citing works

Characterization of the Intracellular Domain of Receptor Activator of NF-κB (RANK)

Darnay, B. G., Haridas, V., Ni, J., Moore, P. A., & Aggarwal, B. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20551 · Cited by 414 · see citing works

Osteoclast Differentiation Factor Acts as a Multifunctional Regulator in Murine Osteoclast Differentiation and Function

Jimi, E., Akiyama, S., Tsurukai, T., Okahashi, N., Kobayashi, K., Udagawa, N., Nishihara, T., Takahashi, N., & Suda, T. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.1.434 · Cited by 404 · see citing works

Interleukin-18 (Interferon-γ–inducing Factor) Is Produced by Osteoblasts and Acts Via Granulocyte/Macrophage Colony-stimulating Factor and Not Via Interferon-γ to Inhibit Osteoclast Formation

Udagawa, N., Horwood, N. J., Elliott, J., Mackay, A., Owens, J., Okamura, H., Kurimoto, M., Chambers, T. J., Martin, T. J., & Gillespie, M. T. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.6.1005 · Cited by 378 · see citing works

RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B.

Ryseck, R.-P., Bull, P., Takamiya, M., Bours, V., Siebenlist, U. K., Dobrzański, P., & Bravo, R. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.2.674 · Cited by 355 · see citing works

4-1BB Ligand Induces Cell Division, Sustains Survival, and Enhances Effector Function of CD4 and CD8 T Cells with Similar Efficacy

Cannons, J. L., Lau, P., Ghumman, B., Debenedette, M. A., Yagita∥, H., Okumura, K., & Watts, T. H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1313 · Cited by 349 · see citing works

Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation

Matsuo, K., Owens, J., Tonko, M., Elliott, C., Chambers, T. J., & Wagner, E. F. (2000) · Nature Genetics · doi:10.1038/72855 · Cited by 341 · see citing works

Modulation of osteoclast differentiation by local factors

Suda, T., Udagawa, N., Nakamura, I., Miyaura, C., & Takahashi, N. (1995) · Bone · doi:10.1016/8756-3282(95)00185-g · Cited by 314 · see citing works

Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection.

Utans, U., Arceci, R. J., Yamashita, Y., & Russell, M. E. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118003 · Cited by 301 · see citing works

The mutational spectrum of human malignant autosomal recessive osteopetrosis

Sobacchi, C. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.17.1767 · Cited by 224 · see citing works

TRAF-interacting Protein (TRIP): A Novel Component of the Tumor Necrosis Factor Receptor (TNFR)- and CD30-TRAF Signaling Complexes That Inhibits TRAF2-mediated NF-κB Activation

Lee, S. Y., Lee, S. Y., & Choi, Y. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.7.1275 · Cited by 195 · see citing works

[20] Role of 1α,25-dihydroxyvitamin D3 in osteoclast differentiation and function

Suda, T., Jimi, E., Nakamura, I., & Takahashi, N. (1997) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(97)82110-6 · Cited by 186 · see citing works

Knockout of the Murine Prostaglandin EP2 Receptor Impairs Osteoclastogenesis in Vitro

Li, X., Okada, Y., Pilbeam, C. C., Lorenzo, J., Kennedy, C., BREYER, R. M., & Raisz, L. G. (2000) · Endocrinology · doi:10.1210/endo.141.6.7518 · Cited by 164 · see citing works

MEF2B Is a Potent Transactivator Expressed in Early Myogenic Lineages

Molkentin, J. D., Firulli, A. B., Black, B. L., Martin, J. F., Hustad, C. M., Copeland, N. G., Jenkins, N. A., Lyons, G. E., & Olson, E. N. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3814 · Cited by 139 · see citing works

A Positive Regulatory Role for Cbl Family Proteins in Tumor Necrosis Factor-related Activation-induced Cytokine (TRANCE) and CD40L-mediated Akt Activation

Arron, J. R., Vologodskaia, M., Wong, B. R., Naramura, M., Kim, N., Gu, H., & Choi, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100414200 · Cited by 128 · see citing works

Genetic and Physical Interactions betweenMicrophthalmia Transcription Factor and PU.1 Are Necessary for Osteoclast Gene Expression and Differentiation

Luchin, A. I., Suchting, S., Merson, T. D., Rosol, T. J., Hume, D. A., Cassady, A. I., & Ostrowski, M. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106418200 · Cited by 123 · see citing works

Colony-stimulating factor-1 induces cytoskeletal reorganization and c-src-dependent tyrosine phosphorylation of selected cellular proteins in rodent osteoclasts.

Insogna, K. L., Sahni, M., Grey, A. B., Tanaka, S., Horne, W. C., Neff, L., Mitnick, M. A., Levy, J. B., & Baron, R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119790 · Cited by 123 · see citing works

Macrophage inflammatory protein-1 alpha and IL-8 stimulate the motility but suppress the resorption of isolated rat osteoclasts.

Fuller, K., Owens, J., & Chambers, T. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.11.6065 · Cited by 116 · see citing works

Immunohistochemical and ultrastructural localization of CGRP-positive nerve fibers at the epiphyseal trabecules facing the growth plate of rat femurs

Hara‐Irie, F., Amizuka, N., & Ozawa, H. (1996) · Bone · doi:10.1016/8756-3282(95)00425-4 · Cited by 113 · see citing works

Receptors for Insulin-Like Growth Factors-I and -II in Osteoblast-Enriched Cultures from Fetal Rat Bone*

McCarthy, T. L., & CANALIS, E. M. (1990) · Endocrinology · doi:10.1210/endo-126-1-39 · Cited by 113 · see citing works

An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor κB ligand

Miyamoto, T. K., Arai, F., Ohneda, O., Takagi, K., Anderson, D. M., & Suda, T. (2000) · Blood · doi:10.1182/blood.v96.13.4335 · Cited by 109 · see citing works

NF‐κB activation through IKK‐i‐dependent I‐TRAF/TANK phosphorylation

Nomura, Kawai, T., Nakanishi, K., & Akira, S. (2000) · Genes to Cells · doi:10.1046/j.1365-2443.2000.00315.x · Cited by 102 · see citing works

A Subclass of Ras Proteins That Regulate the Degradation of IκB

Fenwick, C. W., Na, S.-Y., Voll, R. E., Zhong, H., Im, S., Lee, J. W., & Ghosh, S. (2000) · Science · doi:10.1126/science.287.5454.869 · Cited by 102 · see citing works

Human osteoblasts synthesize and respond to platelet-derived growth factor

Zhang, L., Leeman, E. L., Carnes, D., & Graves, D. T. (1991) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1991.261.2.c348 · Cited by 99 · see citing works

Role of colony‐stimulating factor‐1 in bone metabolism

Felix, R., Hofstetter, W., Wetterwald, A., Cecchini, M. G., & Fleisch, H. A. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240550311 · Cited by 97 · see citing works

Interleukin‐10 selectively inhibits osteoclastogenesis by inhibiting differentiation of osteoclast progenitors into preosteoclast‐like cells in rat bone marrow culture system

Xu, L. X., Kukita, T., Kukita, A., Otsuka, T., Niho, Y., & Iijima, T. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041650321 · Cited by 93 · see citing works

Interleukin-1 induces major phenotypic changes in human skin microvascular endothelial cells

Romero, L. I., Zhang, D.-N., Herron, G. S., & Karasek, M. A. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199710)173:1 · Cited by 88 · see citing works

Cloning, expression, and characterization of a cDNA encoding a novel human growth factor for primitive hematopoietic progenitor cells

Hiraoka, A., Sugimura, A., Seki, T., Nagasawa, T., Ohta, N., Shimonishi, M., Hagiya, M., & Shimizu, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7577 · Cited by 80 · see citing works

Coordinated cytokine expression by stromal and hematopoietic cells during human osteoclast formation

Atkins, G. J., Haynes, D. R., Geary, S. M., Loric, M., Crotti, T. N., & Findlay, D. M. (2000) · Bone · doi:10.1016/s8756-3282(00)00280-5 · Cited by 76 · see citing works

Regulation of ?V?3 and ?V?5 integrins by dexamethasone in normal human osteoblastic cells

Cheng, S., Lai, C.-F., Fausto, A., Chellaiah, M. A., Feng, X., McHugh, K. P., Teitelbaum, S. L., Civitelli, R., Hruska, K. A., Ross, F. P., et al. (2000) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(20000501)77:2 · Cited by 71 · see citing works

Expression of mRNA for axon guidance molecules, such as semaphorin-III, netrins and neurotrophins, in human osteoblasts and osteoclasts

Togari, A., Mogi, M., Arai, M., Yamamoto, S., & Koshihara, Y. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02700-1 · Cited by 65 · see citing works

A New Method to Isolate Large Numbers of Rabbit Osteoclasts and Osteoclast-like Cells: Application to the Characterization of Serum Response Element Binding Proteins During Osteoclast Differentiation

David, J., Neff, L., Chen, Y., Rincón, M., Horne, W. C., & Baron, R. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.11.1730 · Cited by 52 · see citing works

Skeletal dysplasias, growth retardation, reduced postnatal survival, and impaired fertility in mice lacking the SNF2/SWI2 family member ETL1

Schoor, M., Schuster-Gossler, K., Roopenian, D. C., & Gossler, A. (1999) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00090-8 · Cited by 46 · see citing works

Chronicles of a switch hunt: gcm genes in development

Wegner, M., & Riethmacher, D. (2001) · Trends in Genetics · doi:10.1016/s0168-9525(01)02275-2 · Cited by 33 · see citing works

Microphthalmia-Associated Transcription Factor Interacts with PU.1 and c-Fos: Determination of Their Subcellular Localization

Sato, M., Morii, E., Takebayashi‐Suzuki, K., Yasui, N., Ochi, T., Kitamura, Y., & Nomura, S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9918 · Cited by 33 · see citing works

Mast Cells Accumulate in Rat Bone Marrow after Ovariectomy

Lesclous, P., & Jl, S. (1999) · Cells Tissues Organs · doi:10.1159/000016639 · Cited by 30 · see citing works

Proteomic Analysis of Macrophage Differentiation

Csar, X. F., Wilson, N. J., McMahon, K., Marks, D. C., Beecroft, T., Ward, A. C., Whitty, G. A., Kanangasundarum, V., & Hamilton, J. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100213200 · Cited by 26 · see citing works

Mitf mi-enu122 is a missense mutation in the HLH dimerization domain

Steingrı́msson, E., Favor, J., Ferré-D’Amaré, A. R., Copeland, N. G., & Jenkins, N. A. (1998) · Mammalian Genome · doi:10.1007/s003359900736 · Cited by 9 · see citing works

Osteoclast differentiation and activation

Boyle, W. J., Simonet, W. S., & Lacey, D. L. (2003) · Nature · doi:10.1038/nature01658 · Cited by 6,670 · see citing works

Transcriptional regulation by calcium, calcineurin, and NFAT

Hogan, P. G., Chen, L., Nardone, J., & Rao, A. (2003) · Genes & Development · doi:10.1101/gad.1102703 · Cited by 1,991 · see citing works

IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology

Tat, S. K., Marc, P., Théoleyre, S., Heymann, D., & Fortun, Y. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.10.005 · Cited by 959 · see citing works

NF-κB p50 and p52 Regulate Receptor Activator of NF-κB Ligand (RANKL) and Tumor Necrosis Factor-induced Osteoclast Precursor Differentiation by Activating c-Fos and NFATc1*

Yamashita, T., Yao, Z., Li, F., Zhang, Q., Badell, I., Schwarz, E., Takeshita, S., Wagner, E., Noda, M., Matsuo, K., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610701200 · Cited by 412 · see citing works

Large Scale Gene Expression Analysis of Osteoclastogenesisin Vitro and Elucidation of NFAT2 as a Key Regulator

Ishida, N., Hayashi, K., Hoshijima, M., Ogawa, T., Koga, S., Miyatake, Y., Kumegawa, M., Kimura, T., & Takeya, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205063200 · Cited by 377 · see citing works

MCP-1 Is Induced by Receptor Activator of Nuclear Factor-κB Ligand, Promotes Human Osteoclast Fusion, and Rescues Granulocyte Macrophage Colony-stimulating Factor Suppression of Osteoclast Formation

Kim, M. S., Day, C. J., & Morrison, N. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412713200 · Cited by 252 · see citing works

Diminished Bone Formation During Diabetic Fracture Healing is Related to the Premature Resorption of Cartilage Associated With Increased Osteoclast Activity

Kayal, R. A., Tsatsas, D., Bauer, M., Allen, B. W., Al-Sebaei, M. O., Kakar, S., Leone, C. W., Morgan, E. F., Gerstenfeld, L. C., Einhorn, T. A., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.070115 · Cited by 247 · see citing works

Coordinated Activation of Notch, Wnt, and Transforming Growth Factor-β Signaling Pathways in Bone Morphogenic Protein 2-induced Osteogenesis

Zamurovic, N., Cappellen, D., Rohner, D., & Šuša, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403813200 · Cited by 234 · see citing works

Parathyroid Hormone Stimulates Osteoblastic Expression of MCP-1 to Recruit and Increase the Fusion of Pre/Osteoclasts

Li, X., Qin, L., Bergenstock, M., Bevelock, L. M., Novack, D. V., & Partridge, N. C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611781200 · Cited by 232 · see citing works

Osteoclast precursors, RANKL/RANK, and immunology

Xing, L., Schwarz, E. M., & Boyce, B. F. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00336.x · Cited by 234 · see citing works

Parathyroid Hormone Stimulates Receptor Activator of NFκB Ligand and Inhibits Osteoprotegerin Expression via Protein Kinase A Activation of cAMP-response Element-binding Protein

Fu, Q., Jilka, R. L., Manolagas, S. C., & O’Brien, C. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208494200 · Cited by 224 · see citing works

Effects of glucose-dependent insulinotropic peptide on osteoclast function

Zhong, Q., Itokawa, T., Sridhar, S., Ding, K., Xie, D., Kang, B., Bollag, W. B., Bollag, R. J., Hamrick, M. W., Insogna, K. L., et al. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00364.2006 · Cited by 206 · see citing works

Molecular Pathways: Osteoclast-Dependent and Osteoclast-Independent Roles of the RANKL/RANK/OPG Pathway in Tumorigenesis and Metastasis

Dougall, W. C. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2507 · Cited by 200 · see citing works

Signaling Networks that Control the Lineage Commitment and Differentiation of Bone Cells

Soltanoff, C. S., Yang, S., Chen, W., & Li, Y. (2009) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v19.i1.10 · Cited by 196 · see citing works

Osteoclasts are important for bone angiogenesis

Cackowski, F. C., Anderson, J. L., Patrene, K. D., Choksi, R. J., Shapiro, S. D., Windle, J. J., Blair, H. C., & Roodman, G. D. (2010) · Blood · doi:10.1182/blood-2009-08-237628 · Cited by 188 · see citing works

RANKL-Mediated Osteoclast Formation from Murine RAW 264.7 cells

Collin‐Osdoby, P., & Osdoby, P. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-415-5_13 · Cited by 174 · see citing works

β1 integrins regulate mammary gland proliferation and maintain the integrity of mammary alveoli

Li, N., Zhang, Y., Naylor, M. J., Schatzmann, F., Maurer, F., Wintermantel, T. M., Schüetz, G., Mueller, U. W., Streuli, C. H., & Hynes, N. E. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600674 · Cited by 168 · see citing works

Minireview: Transcriptional Regulation in Development of Bone

Kobayashi, T., & Kronenberg, H. M. (2004) · Endocrinology · doi:10.1210/en.2004-1343 · Cited by 158 · see citing works

Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts

Kneissel, M., Luong-Nguyen, N.-H., Baptist, M., Cortesi, R., Zumstein-Mecker, S., Κοσσίδα, Σ., O’Reilly, T. E., Lane, H. A., & Šuša, M. (2004) · Bone · doi:10.1016/j.bone.2004.07.013 · Cited by 158 · see citing works

Atp6v0d2 Is an Essential Component of the Osteoclast-Specific Proton Pump That Mediates Extracellular Acidification in Bone Resorption

Wu, H., Xu, G., & Li, Y. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081239 · Cited by 145 · see citing works

Memo mediates ErbB2-driven cell motility

Marone, R., Heß, D., Dankort, D. L., Muller, W. J., Hynes, N. E., & Badache, A. (2004) · Nature Cell Biology · doi:10.1038/ncb1134 · Cited by 146 · see citing works

Withaferin A: a proteasomal inhibitor promotes healing after injury and exerts anabolic effect on osteoporotic bone

Khedgikar, V., Kushwaha, P., Gautam, J., Verma, A., Changkija, B., Kumar, A., Sharma, S., Nagar, G., Singh, D. R., Trivedi, P. K., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.294 · Cited by 139 · see citing works

Dysregulation of bone remodeling by imatinib mesylate

Vandyke, K., Fitter, S., Dewar, A. L., Hughes, T. P., & Zannettino, A. C. W. (2009) · Blood · doi:10.1182/blood-2009-08-237404 · Cited by 138 · see citing works

RANKL-Mediated Osteoclast Formation from Murine RAW 264.7 Cells

Collin‐Osdoby, P., Yu, X., Zheng, H., & Osdoby, P. (2003) · Humana Press eBooks · doi:10.1385/1-59259-366-6:153 · Cited by 135 · see citing works

IL‐23 promotes osteoclast formation by up‐regulation of receptor activator of NF‐κB (RANK) expression in myeloid precursor cells

Chen, L., Wei, X., Evans, B. A. J., Jiang, W. G., & Aeschlimann, D. P. (2008) · European Journal of Immunology · doi:10.1002/eji.200838192 · Cited by 133 · see citing works

Osteoclast differentiation and gene regulation

Zhao, Q. (2006) · Frontiers in bioscience · doi:10.2741/2252 · Cited by 129 · see citing works

Macrophage fusion: are somatic and cancer cells possible partners?

Vignery, A. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.02.008 · Cited by 123 · see citing works

Personalized medicine: an update of salivary biomarkers for periodontal diseases

Korte, D. L., & Kinney, J. S. (2015) · Periodontology 2000 · doi:10.1111/prd.12103 · Cited by 119 · see citing works

Gene expression profile of the bone microenvironment in human fragility fracture bone

Hopwood, B., Tsykin, A., Findlay, D. M., & Fazzalari, N. L. (2008) · Bone · doi:10.1016/j.bone.2008.08.120 · Cited by 114 · see citing works

Novel c‐MYC target genes mediate differential effects on cell proliferation and migration

Cappellen, D., Schlange, T., Bauer, M., Maurer, F., & Hynes, N. E. (2006) · EMBO Reports · doi:10.1038/sj.embor.7400849 · Cited by 110 · see citing works

Functional Expression of β-Chemokine Receptors in Osteoblasts: Role of Regulated upon Activation, Normal T Cell Expressed and Secreted (RANTES) in Osteoblasts and Regulation of Its Secretion by Osteoblasts and Osteoclasts

Yano, S., Mentaverri, R., Kanuparthi, D., Bandyopadhyay, S., Rivera, A., Brown, E. M., & Chattopadhyay, N. (2005) · Endocrinology · doi:10.1210/en.2005-0065 · Cited by 104 · see citing works

MCP-1 expressed by osteoclasts stimulates osteoclastogenesis in an autocrine/paracrine manner

Miyamoto, K., Ninomiya, K., Sonoda, K., Miyauchi, Y., Hoshi, H., Iwasaki, R., Miyamoto, H., Yoshida, S., Sato, Y., Morioka, H., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.020 · Cited by 94 · see citing works

The origins and formation of bone-resorbing osteoclasts

Elson, A., Anuj, A., Barnea-Zohar, M., & Reuven, N. (2022) · Bone · doi:10.1016/j.bone.2022.116538 · Cited by 95 · see citing works

Targeted deletion of histidine decarboxylase gene in mice increases bone formation and protects against ovariectomy-induced bone loss

Fitzpatrick, L. A., Buzás, E. I., Gagne, T. J., Nagy, A., Horvath, C., Ferencz, V., Mester, A., Kari, B., Ruan, M., Falus, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0934373100 · Cited by 92 · see citing works

The Tumor Necrosis Factor Superfamily Member RANKL Suppresses Effector Cytokine Production in Group 3 Innate Lymphoid Cells

Bando, J. K., Gilfillan, S., Song, C., McDonald, K. G., Huang, S. C., Newberry, R. D., Kobayashi, Y., Allan, D., Carlyle, J. R., Cella, M., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.012 · Cited by 92 · see citing works

The tyrosine kinase inhibitor dasatinib dysregulates bone remodeling through inhibition of osteoclasts in vivo

Vandyke, K., Dewar, A. L., Diamond, P., Fitter, S., Schultz, C. G., Sims, N. A., & Zannettino, A. C. W. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.85 · Cited by 89 · see citing works

Molecular Basis of Requirement of Receptor Activator of Nuclear Factor κB Signaling for Interleukin 1-mediated Osteoclastogenesis

Jules, J., Zhang, P., Ashley, J. W., Shi, W., Shi, Z., Liu, J., Michalek, S. M., & Feng, X. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.296228 · Cited by 85 · see citing works

MIP-1γ Promotes Receptor Activator of NF-κB Ligand-Induced Osteoclast Formation and Survival

Okamatsu, Y., Kim, D. S., Battaglino, R. A., Sasaki, H., Späte, U., & Stashenko, P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.2084 · Cited by 81 · see citing works

CCL2/Monocyte Chemoattractant Protein 1 and Parathyroid Hormone Action on Bone

Siddiqui, J. A., & Partridge, N. C. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00049 · Cited by 79 · see citing works

MDA-MB-231 breast cancer cells fuel osteoclast metabolism and activity: A new rationale for the pathogenesis of osteolytic bone metastases

Lemma, S., Pompo, G. D., Porporato, P. E., Sboarina, M., Russell, S., Gillies, R. J., Baldini, N., Sonveaux, P., & Avnet, S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.08.030 · Cited by 77 · see citing works

Human interleukin-1-induced murine osteoclastogenesis is dependent on RANKL, but independent of TNF-alpha.

Ma, T., Miyanishi, K., Suen, A., Epstein, N. J., Tomita, T., Smith, R. L., & Goodman, S. (2004) · Cytokine · doi:10.1016/j.cyto.2004.02.001 · Cited by 88 · see citing works

Inflammation-Induced Bone Loss: Can it Be Prevented?

Romas, E., & Gillespie, M. T. (2006) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2006.07.004 · Cited by 78 · see citing works

Genome-wide expression analyses establish dendritic cells as a new osteoclast precursor able to generate bone-resorbing cells more efficiently than monocytes

Gallois, A., Lachuer, J., Yvert, G., Wierinckx, A., Brunet, F., Rabourdin-Combe, C., Delprat, C., Jurdic, P., & Mazzorana, M. (2010) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090829 · Cited by 75 · see citing works

Retinoid-induced bone thinning is caused by subperiosteal osteoclast activity in adult rodents

Kneissel, M., Studer, A., Cortesi, R., & Šuša, M. (2005) · Bone · doi:10.1016/j.bone.2004.11.006 · Cited by 75 · see citing works

Platelet Dysfunction and a High Bone Mass Phenotype in a Murine Model of Platelet-Type von Willebrand Disease

Suva, L. J., Hartman, E., Dilley, J. D., Russell, S., Akel, N. S., Skinner, R. A., Hogue, W. R., Budde, U., Varughese, K. I., Kanaji, T., et al. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070417 · Cited by 75 · see citing works

The skeleton as a unique environment for breast cancer cells

Mastro, A. M., Gay, C. V., & Welch, D. R. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1022995403081 · Cited by 76 · see citing works

Chemerin neutralization blocks hematopoietic stem cell osteoclastogenesis

Muruganandan, S., Dranse, H. J., Rourke, J. L., McMullen, N. M., & Sinal, C. J. (2013) · Stem Cells · doi:10.1002/stem.1450 · Cited by 74 · see citing works

Activation of peroxisome proliferator-activated receptor γ inhibits TNF-α-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression

Hounoki, H., Sugiyama, E., Mohamed, S. G.-K., Shinoda, K., Taki, H., Abdel-Aziz, H. O., Maruyama, M., Kobayashi, M., & Miyahara, T. (2008) · Bone · doi:10.1016/j.bone.2007.11.016 · Cited by 73 · see citing works

Dietary nutraceuticals as backbone for bone health

Pandey, M. K., Gupta, S. C., Karelia, D. N., Gilhooley, P. J., Shakibaei, M., & Aggarwal, B. B. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.03.014 · Cited by 73 · see citing works

Increased expression of IL-6 and RANK mRNA in human trabecular bone from fragility fracture of the femoral neck.

Tsangari, H., Findlay, D. M., Kuliwaba, J. S., Atkins, G. J., & Fazzalari, N. L. (2004) · Bone · doi:10.1016/j.bone.2004.02.006 · Cited by 69 · see citing works

Ubiquitous overexpression of Hey1 transcription factor leads to osteopenia and chondrocyte hypertrophy in bone

Salie, R., Kneissel, M., Vukevic, M., Zamurovic, N., Krämer, I., Evans, G. L., Gerwin, N., Müeller, M., Kinzel, B., & Šuša, M. (2009) · Bone · doi:10.1016/j.bone.2009.10.022 · Cited by 68 · see citing works

Exposure to receptor-activator of NFκB ligand renders pre-osteoclasts resistant to IFN-γ by inducing terminal differentiation

Huang, W., O'Keefe, R., & Schwarz, E. (2002) · Arthritis Research & Therapy · doi:10.1186/ar612 · Cited by 69 · see citing works

gp130-Mediated Signaling Is Necessary for Normal Osteoblastic Function in Vivo and in Vitro

Shin, H., Pajevic, P. D., Sims, N. A., Kobayashi, T., Miao, D., Karaplis, A. C., Baron, R., Bringhurst, R., & Kronenberg, H. M. (2003) · Endocrinology · doi:10.1210/en.2003-0839 · Cited by 66 · see citing works

Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation

Boyle, K., Zhang, J., Nicholson, S. E., Trounson, E., Babon, J. J., McManus, E. J., Nicola, N. A., & Robb, L. G. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.11.002 · Cited by 66 · see citing works

Next-generation transcriptome sequencing of the premenopausal breast epithelium using specimens from a normal human breast tissue bank

Pardo, I., Lillemoe, H. A., Blosser, R. J., Choi, M.-R., Sauder, C. A. M., Doxey, D. K., Mathieson, T., Hancock, B. A., Baptiste, D. F., Atale, R. V., et al. (2014) · Breast Cancer Research · doi:10.1186/bcr3627 · Cited by 61 · see citing works

IL-1 receptor–associated kinase M is a central regulator of osteoclast differentiation and activation

Li, H., Cuartas, E., Cui, W., Choi, Y., Crawford, T. D., Ke, H. Z., Kobayashi, K. S., Flavell, R. A., & Vignery, A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041444 · Cited by 61 · see citing works

Systemic Inhibition of Canonical Notch Signaling Results in Sustained Callus Inflammation and Alters Multiple Phases of Fracture Healing

Dishowitz, M. I., Mutyaba, P. L., Takacs, J. D., Barr, A. M., Engiles, J. B., Ahn, J., & Hankenson, K. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068726 · Cited by 64 · see citing works

Inhibition of osteoclast differentiation by polycyclic aryl hydrocarbons is dependent on cell density and RANKL concentration

Voronov, I., Heersche, J. N. M., Casper, R. F., Tenenbaum, H. C., & Manolson, M. F. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.028 · Cited by 63 · see citing works

Mice Lacking the Integrin β5 Subunit Have Accelerated Osteoclast Maturation and Increased Activity in the Estrogen-Deficient State

Lane, N. E., Yao, W., Nakamura, M. C., Humphrey, M. B., Kimmel, D. B., Huang, X., Sheppard, D., Ross, F. P., & Teitelbaum, S. L. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041017 · Cited by 62 · see citing works

Temporal differential effects of proinflammatory cytokines on osteoclastogenesis

Moon, S.-J., Ahn, I. E., Jung, H., Yi, H., Kim, J., Kim, Y., Kwok, S.-K., Park, K.-S., Min, J., Park, S.-H., et al. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1269 · Cited by 67 · see citing works

Conjugated linoleic acid protects against age-associated bone loss in C57BL/6 female mice

Rahman, M. M., Bhattacharya, A., Banu, J., & Fernandes, G. (2006) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.08.002 · Cited by 59 · see citing works

Cell signaling and transcriptional regulation of osteoclast lineage commitment, differentiation, bone resorption and diseases

Zhu, S., Yan, M.-Q., Masson, A., Chen, W. "., & Li, Y. (2026) · Cell Discovery · doi:10.1038/s41421-025-00853-6 · Cited by 64 · see citing works

Osteoclast Fusion: Physiological Regulation of Multinucleation through Heterogeneity—Potential Implications for Drug Sensitivity

Søe, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207717 · Cited by 58 · see citing works

Mechanisms of bone loss in rheumatoid arthritis

Findlay, D. M., & Haynes, D. R. (2005) · Modern Rheumatology · doi:10.1007/s10165-005-0412-z · Cited by 55 · see citing works

IL-15 promotes osteoclastogenesis via the PLD pathway in rheumatoid arthritis.

Park, M.-K., Her, Y.-M., Mi, L.-C., Oh, H., Park, E.-M., Kwok, S.-K., Ju, J., Park, K.-S., Min, D.-S., Kim, H.-Y., et al. (2011) · Immunology Letters · doi:10.1016/j.imlet.2011.04.013 · Cited by 50 · see citing works

Osteoclasts and Microgravity

Smith, J. K. (2020) · Life · doi:10.3390/life10090207 · Cited by 52 · see citing works

Comparative study of protein and mRNA expression during osteoclastogenesis

Czupalla, C., Mansukoski, H., Pursche, T., Krause, E., & Hoflack, B. (2005) · PROTEOMICS · doi:10.1002/pmic.200402059 · Cited by 52 · see citing works

Gene array identification of osteoclast genes: Differential inhibition of osteoclastogenesis by cyclosporin A and granulocyte macrophage colony stimulating factor

Day, C. J., Kim, M. S., Stephens, S., Simcock, W. E., Aitken, C. J., Nicholson, G. C., & Morrison, N. A. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10780 · Cited by 52 · see citing works

The High Rate of Bone Resorption in Multiple Myeloma is due to RANK (Receptor Activator of Nuclear Factor-κB) and RANK Ligand Expression

Roux, S., & Xavier Mariette, A. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194310001593193 · Cited by 52 · see citing works

Proinflammatory mediator expression in a novel murine model of titanium‐particle–induced intramedullary inflammation

Warme, B. A., Epstein, N. J., Trindade, M. C. D., Miyanishi, K., Ma, T., Saket, R. R., Regula, D. P., Goodman, S. B., & Smith, R. L. (2004) · Journal of Biomedical Materials Research Part B Applied Biomaterials · doi:10.1002/jbm.b.30120 · Cited by 51 · see citing works

Osteoclast formation at the bone marrow/bone surface interface: Importance of structural elements, matrix, and intercellular communication

Søe, K., Delaisse, J.-M., & Borggaard, X. G. (2021) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2020.05.016 · Cited by 49 · see citing works

State of Evidence on Oral Health Problems in Diabetic Patients: A Critical Review of the Literature

González‐Moles, M. Á., & Ramos‐García, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10225383 · Cited by 50 · see citing works

Interleukin‐4 inhibits RANKL‐induced NFATc1 expression via STAT6: A novel mechanism mediating its blockade of osteoclastogenesis

Cheng, J. Q., Liu, J., Shi, Z., Xu, D., Luo, S., Siegal, G. P., Feng, X., & Shi, W. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23269 · Cited by 50 · see citing works

CCN3 promotes prostate cancer bone metastasis by modulating the tumor–bone microenvironment through RANKL-dependent pathway

Chen, P., Cheng, H., & Tang, C. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt103 · Cited by 49 · see citing works

WNT/β-Catenin Signaling Is Involved in Regulation of Osteoclast Differentiation by Human Immunodeficiency Virus Protease Inhibitor Ritonavir

Modarresi, R., Xiang, Z., Yin, M. T., & Laurence, J. C. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080484 · Cited by 48 · see citing works

IL-1R/TLR2 through MyD88 Divergently Modulates Osteoclastogenesis through Regulation of Nuclear Factor of Activated T Cells c1 (NFATc1) and B Lymphocyte-induced Maturation Protein-1 (Blimp1)

Chen, Z., Su, L., Xu, Q., Katz, J., Michalek, S. M., Fan, M., Feng, X., & Zhang, P. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.663518 · Cited by 47 · see citing works

Growth/differentiation factor-15 inhibits differentiation into osteoclasts—A novel factor involved in control of osteoclast differentiation

Vaňhara, P., Slabáková, E., Kozubı́k, A., Jurdic, P., Souček, K., & Šmarda, J. (2009) · Differentiation · doi:10.1016/j.diff.2009.07.008 · Cited by 45 · see citing works

Association between Postmenopausal Osteoporosis and Experimental Periodontitis

Luo, K., Ma, S., Guo, J., Huang, Y., Yan, F., & Xiao, Y. (2014) · BioMed Research International · doi:10.1155/2014/316134 · Cited by 44 · see citing works

Hyperocclusion Stimulates Osteoclastogenesis via CCL2 Expression

Goto, K., Kajiya, H., Nemoto, T., Tsutsumi, T., Tsuzuki, T., Sato, H., & Okabe, K. (2011) · Journal of Dental Research · doi:10.1177/0022034511400742 · Cited by 43 · see citing works

Cyclosporine A and FK506 induce osteoclast apoptosis in mouse bone marrow cell cultures

Igarashi, K., Hirotani, H., Woo, J.-T., & Stern, P. H. (2004) · Bone · doi:10.1016/j.bone.2004.02.009 · Cited by 43 · see citing works

Biological mechanisms of bone and cartilage remodelling—genomic perspective

Borovečki, F., Pećina‐Šlaus, N., & Vukičević, S. (2007) · International Orthopaedics · doi:10.1007/s00264-007-0408-8 · Cited by 43 · see citing works

Differential Expression of Chemokines, Chemokine Receptors and Proteinases by Foreign Body Giant Cells (FBGCs) and Osteoclasts

Khan, U. A., Hashimi, S. M., Khan, S., Quan, J., Bakr, M. M., Forwood, M. R., & Morrison, N. A. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24781 · Cited by 42 · see citing works

Changes in receptor activator of nuclear factor‐kappaB, and its ligand, osteoprotegerin, bone‐type alkaline phosphatase, and tartrate‐resistant acid phosphatase in ovariectomized rats

Miyazaki, T., Matsunaga, T., Miyazaki, S., Hokari, S., & Komoda, T. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20201 · Cited by 41 · see citing works

Receptor Activator of NF-κB (RANK) Cytoplasmic IVVY535–538 Motif Plays an Essential Role in Tumor Necrosis Factor-α (TNF)-mediated Osteoclastogenesis*

Jules, J., Shi, Z.-Q., Liu, J.-Z., Xu, D., Wang, S.-Q., & Feng, X. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.149484 · Cited by 38 · see citing works

FK506 protects against articular cartilage collagenous extra-cellular matrix degradation

Siebelt, M., van der Windt, A. E., Groen, H. C., Sandker, M., Waarsing, J. H., Müller, C., de Jong, M., Jahr, H., & Weinans, H. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.02.003 · Cited by 39 · see citing works

Mice Lacking the Integrin 5 Subunit Have Accelerated Osteoclast Maturation and Increased Activity in the Estrogen-Deficient State

Lane, N. E., Yao, W., Nakamura, M. C., Humphrey, M. B., Kimmel, D. B., Huang, X., Sheppard, D., Ross, F. P., & Teitelbaum, S. L. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2005.20.1.58 · Cited by 39 · see citing works

The bacterial gene lfpA influences the potent induction of calcitonin receptor and osteoclast-related genes in Burkholderia pseudomallei-induced TRAP-positive multinucleated giant cells

Boddey, J. A., Day, C. J., Flegg, C. P., Ulrich, R. L., Stephens, S., Beacham, I. R., Morrison, N. A., & Peak, I. R. A. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00807.x · Cited by 39 · see citing works

t10c12‐CLA maintains higher bone mineral density during aging by modulating osteoclastogenesis and bone marrow adiposity

Rahman, M. M., Halade, G. V., Williams, P. J., & Fernandes, G. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22578 · Cited by 38 · see citing works

Oleanolic acid exerts bone protective effects in ovariectomized mice by inhibiting osteoclastogenesis

Zhao, D., Li, X., Zhao, Y., Qiao, P., Tang, D., Chen, Y., Xue, C., Li, C., Liu, S., Wang, J., et al. (2018) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2018.03.007 · Cited by 38 · see citing works

Regulation of osteoclast structure and function by FAK family kinases

Ray, B. J., Thomas, K. S., Huang, C. S., Gutknecht, M. F., Botchwey, E. A., & Bouton, A. H. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0512259 · Cited by 37 · see citing works

Native, not nitrated, cytochrome c and mitochondria-derived hydrogen peroxide drive osteoclast apoptosis

Oursler, M. J., Bradley, E. W., Elfering, S. L., & Giulivi, C. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00092.2004 · Cited by 37 · see citing works

Mast cell activation and degranulation occur early during induction of periosteal bone resorption

Fouilloux, I., Duplan, M. B., Baroukh, B., Cherruau, M., Jl, S., & Lesclous, P. (2005) · Bone · doi:10.1016/j.bone.2005.07.026 · Cited by 35 · see citing works

Molecular Mechanisms of the Biphasic Effects of Interferon-γ on Osteoclastogenesis

Cheng, J. Q., Liu, J., Shi, Z., Jules, J., Xu, D., Luo, S., Shi, W., & Feng, X. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0019 · Cited by 35 · see citing works

Platinum nanoparticles reduce ovariectomy-induced bone loss by decreasing osteoclastogenesis

Kim, W.-K., Kim, J.-C., Park, H.-J., Sul, O., Lee, M., Kim, J.-S., & Choi, H. (2012) · Experimental & Molecular Medicine · doi:10.3858/emm.2012.44.7.048 · Cited by 34 · see citing works

Cyclophosphamide causes osteoporosis in C57BL/6 male mice: suppressive effects of cyclophosphamide on osteoblastogenesis and osteoclastogenesis

Zhao, D., Wang, C., Zhao, Y., Shu, B., Jia, Y., Liu, S., Wang, H., Chang, J., Dai, W., Lü, S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21000 · Cited by 32 · see citing works

Gene expression profiling of bone marrow stromal cells from juvenile, adult, aged and osteoporotic rats: With an emphasis on osteoporosis

Xiao, Y., Fu, H., Prasadam, I., Yang, Y.-C., & Hollinger, J. O. (2006) · Bone · doi:10.1016/j.bone.2006.10.021 · Cited by 32 · see citing works

An in vitro 3D bone metastasis model by using a human bone tissue culture and human sex-related cancer cells

Salamanna, F., Borsari, V., Brogini, S., Giavaresi, G., Parrilli, A., Cepollaro, S., Cadossi, M., Martini, L., Mazzotti, A., & Fini, M. (2016) · Oncotarget · doi:10.18632/oncotarget.12763 · Cited by 31 · see citing works

The Cyprinodon variegatus genome reveals gene expression changes underlying differences in skull morphology among closely related species

Lencer, E. S., Warren, W. C., Harrison, R., & McCune, A. R. (2017) · BMC Genomics · doi:10.1186/s12864-017-3810-7 · Cited by 31 · see citing works

The Natural History of Charcot's Neuroarthropathy

Nielson, D. L., & Armstrong, D. G. (2008) · Clinics in Podiatric Medicine and Surgery · doi:10.1016/j.cpm.2007.10.004 · Cited by 31 · see citing works

The naturally derived small compound Osthole inhibits osteoclastogenesis to prevent ovariectomy-induced bone loss in mice

Zhao, D., Wang, Q., Zhao, Y., Zhang, H., Sha, N., Tang, D., Liu, S., Lü, S., Shi, Q., Zhang, Y., et al. (2018) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001150 · Cited by 29 · see citing works

Macrophage Colony-Stimulating Factor (MCSF) and Receptor Activator of NF₭B Ligand (RANKL) in Osteoclastogenesis

Pakan, P. D., Alanazi, A. F. R., & Andronicos, N. M. (2021) · International Journal of Current Research and Review · doi:10.31782/ijcrr.2021.131234 · Cited by 1 · see citing works

Receptor Activator of NF₭B Ligand Stimulates the Differentiation of Osteoclast Progenitors of the Macrophage Lineage into Osteoclasts in the Presence of Macrophage Colony-Stimulating FactorPreprint

Pakan, P. D. (2017) · doi:10.31227/osf.io/fc6uv

RANK Signaling Pathways and Key Molecules Inducing Osteoclast Differentiation

Lee, N. K. (2017) · Journal of Experimental & Biomedical Sciences/Biomedical Science Letters · doi:10.15616/bsl.2017.23.4.295 · Cited by 11 · see citing works

Signaling Pathways in Osteoclast Differentiation

Kim, J. H., & Kim, N. (2016) · Chonnam Medical Journal · doi:10.4068/cmj.2016.52.1.12 · Cited by 264 · see citing works

RANKL strongly induces the GM-CSF receptor during osteoclast differentiation but continuous exposure to GM-CSF represses osteoclast formation.

Kim, M. S. H., Day, C. J., & Morrison, N. A. (2003) · Griffith Research Online